A patient walks into a thoracic surgery consultation with a small lung tumor, stage I on every scan, and every conventional ...

A new approach using lipid nanoparticles to deliver genetic material is showing promise in tackling two major challenges in lung cancer at once.

SHANGHAI, April 10 (Reuters) - Amgen's lung cancer drug tarlatamab has won approval from China's National Medical Products Administration, its development and commercialisation partner BeOne Medicines ...

Leah Phillips was diagnosed with Stage 4 lung cancer at 43. She never smoked, but a genetic mutation allowed the cancer to ...

Screening rules are too narrow and keep patients from receiving care until it’s too late, say many Boston-area researchers ...

New research suggests heavy marijuana smoking may raise the risk of lung cancer risk, as well as head and neck cancer.

Screening individuals for lung cancer with low-dose CT on a nonrisk basis is associated with a marked reduction in lung cancer mortality and better overall survival, reveals Chinese data.

Plus, what to know before making an appointment.

A new study co-led by the Institute for Systems Biology (ISB) shows that some lung cancers can change identity as they evolve ...

Lung cancer remains the leading cause of cancer deaths in the United States, with a new diagnosis every two minutes. In Tampa ...

Cancer rates in Canada will remain high in 2026. Lung, breast, prostate, and colorectal cancers will be the most common, ...